Your browser doesn't support javascript.
loading
Improving the In Vivo Efficacy of an Anti-Tac (CD25) Immunotoxin by Pseudomonas Exotoxin A Domain II Engineering.
Kaplan, Gilad; Mazor, Ronit; Lee, Fred; Jang, Youjin; Leshem, Yasmin; Pastan, Ira.
Affiliation
  • Kaplan G; Laboratory of Molecular Biology, Center for Cancer Research, NCI, NIH, Bethesda, Maryland.
  • Mazor R; Laboratory of Molecular Biology, Center for Cancer Research, NCI, NIH, Bethesda, Maryland.
  • Lee F; Laboratory of Molecular Biology, Center for Cancer Research, NCI, NIH, Bethesda, Maryland.
  • Jang Y; Laboratory of Molecular Biology, Center for Cancer Research, NCI, NIH, Bethesda, Maryland.
  • Leshem Y; Laboratory of Molecular Biology, Center for Cancer Research, NCI, NIH, Bethesda, Maryland.
  • Pastan I; Laboratory of Molecular Biology, Center for Cancer Research, NCI, NIH, Bethesda, Maryland. pastani@mail.nih.gov.
Mol Cancer Ther ; 17(7): 1486-1493, 2018 07.
Article in En | MEDLINE | ID: mdl-29695631

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bacterial Toxins / Protein Engineering / ADP Ribose Transferases / Hematologic Neoplasms / Virulence Factors / Exotoxins / Antibodies, Monoclonal Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Mol Cancer Ther Journal subject: ANTINEOPLASICOS Year: 2018 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bacterial Toxins / Protein Engineering / ADP Ribose Transferases / Hematologic Neoplasms / Virulence Factors / Exotoxins / Antibodies, Monoclonal Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Mol Cancer Ther Journal subject: ANTINEOPLASICOS Year: 2018 Type: Article